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Recurrent symptomatic aortic sac seroma after
open abdominal aortic aneurysm repair
Robert F. Cuff, MD,a and James H. Thomas, MD,b Grand Rapids, Mich; and Kansas City, Kan
The expansion of an abdominal aortic aneurysm sac after conventional repair has been rarely described. All cases in the
literature have been associated with polytetrafluoroethylene grafts and perigraft seromas. We present a patient with a
recurrent, symptomatic periaortic graft seroma after conventional repair. The etiology of this problem along with its
potential increasing significance in the endovascular era is reviewed. (J Vasc Surg 2005;41:1058-60.)CASE REPORT
Three years after undergoing an elective aortobiiliac bypass via
a midline incision for a 9-cm abdominal aortic aneurysm, a 71-
year-old man presented with a 1-week history of worsening mid
abdominal pain, nausea, and abdominal fullness. An abdominal
ultrasound examination demonstrated a large fluid collection
around the patent graft.
The patient had a palpable pulsatile mass in the mid abdomen
and a normal peripheral vascular exam. A spiral computed tomog-
raphy (CT) scan of the abdomen and pelvis showed a large,
perigraft fluid collection without evidence of active contrast extrav-
asation or wall enhancement (Fig 1, A) Hounsfield units were
intermediate between simple fluid and blood. No other intra-
abdominal pathology was noted. An arteriogram showed no vas-
cular communication with the fluid collection (Fig 1, B).
Over the next 24 hours, the patient had increasing abdominal
pain. An exploratory laparotomy was performed, and the enlarged
aneurysm sac was easily appreciated in the retroperitoneum (Fig 2, A).
The sac contained a slightly viscous, cloudy fluid. There was no
hematoma or bleeding within the aneurysm sac. The polytetrafluoro-
ethylene (PTFE) graft (manufacturer unknown) was intact and had a
viscous, gel-like substance on it (Figure 2, B).
Resection of the redundant sac and loose reapproximation of
the edges was performed. The patient’s abdominal pain resolved,
and he was discharged home on postoperative day 6.
He did well until 2 months later, when he began to have vague
abdominal discomfort and fullness. A spiral CT scan showed
recurrent filling of the aneurysm sac (Fig 3). Upon re-exploration,
the PTFE graft was surrounded by a gelatinous coating and thin
serous fluid, without evidence of pseudoaneurysm or leak. Resec-
tion of the PTFE graft and replacement with a Dacron (DuPont)
graft was performed. The remaining sac was closed around the
graft.
Cultures were obtained from the fluid, gelatinous coating, and
excised graft material; serologic and coagulation studies were
obtained on the fluid sample. All Gram stains and cultures were
negative. The chemical studies were consistent with a serous tran-
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1058sudate, and coagulation studies showed no increased fibrinolytic
activity. The patient’s abdominal pain resolved, and he was dis-
charged home on postoperative day 5. He has remained asymp-
tomatic andwithout evidence of recurrent hygroma onCT for over
18 months.
DISCUSSION
Perigraft seromas have been reported in association
with a variety of conventional vascular procedures.1-8 A
survey of vascular surgeons in 1985 revealed an estimated
279 cases.5 Most were in superficially placed grafts, with
axillofemoral and femorofemoral bypasses accounting for
58% of the total. Deep graft seromas occurred much less
frequently, accounting for10% of the cases in the survey.
Shah et al9 found no cases of perigraft seromas in over
1,000 cases with stretch PTFE aortoiliac grafts placed for
aneurysmal and occlusive disease.5 Re-expansion of an aor-
tic aneurysm sac after conventional aortic aneurysm repair is
rare, with only five such cases reported in the English
literature.1-4 All five were associated with perigraft seromas
and PTFE grafts.
Four etiologies have been proposed for the develop-
ment of perigraft seromas:
The first is due to a low-grade infection, with formation
of a biofilm and reactive seroma. This is often seen with
indolent infections years after graft placement.
The second is related to an immunologic reaction to
the graft material.8 There appeared to be an increased
incidence of seromas in patients with knitted Dacron grafts
and PTFE grafts, which accounted for approximately 88%
of cases in the survey.5 Resolution of the seroma has
occurred with replacement of a Dacron graft with a PTFE
graft and vice versa, which may indicate a patient-specific
tolerance to certain grafts.5,8
The third theory is related to the extravasation of a
serous ultrafiltrate through the graft. This is a flow-related
phenomenon that has been has been demonstrated to
occur with PTFE grafts both in vitro and clinically.1-5,7,8
Recently, Risberg et al2 expanded upon this theory by
proposing that the seroma develops as a result of increased
activation of the fibrinolytic cascade with the development
of a proteinaceous perigraft fluid collection which then
increases the draw of fluid across the PTFE membrane.
They found high levels of proteins associated with throm-
bus degradation within the sac and proposed that this was
ut co
ering
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thrombus activating the fibrinolytic cascade.
Several studies have shown an increased incidence of
delayed sac growth in PTFE endografts, and W.L. Gore &
Associates recently released the results of the Excluder
Abdominal Aortic EndoprosthesisMulticenter Pivotal trial,
Fig 1. (A) Computed tomography scan demonstrate
subtraction angiogram shows an intact aortic graft witho
Fig 2. (A) Intraoperative photograph of the pressurize
polytetrafluoroethylene graft encased in a gelatinous covwhich evaluated the 4-year results of the Gore Excluderendoprosthesis.10-13 This confirmed a trend of increasing
sac size without endoleak over the 4-year experience.
Nearly one third of all patients experienced sac enlargement
by 48 months, and over half of these patients had no
evidence of endoleak.
An evaluation of cases of explanted Excluder grafts
erigraft seroma and distended aortic sac. (B) Digital
mmunication with the perigraft seroma.
tic sac. (B) Intraoperative photograph shows the intact
within the aortic sac.s a pd aorrevealed perigraft seromas and a gelatinous, fibrinous de-
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removed from the sac during an endovascular repair, the
Risberg group’s theory may account for the increased inci-
dence of seroma formation and sac expansion seen in
endovascular PTFE repairs compared with conventional
repairs.
A modified PTFE version of the Excluder graft has
been released to address the problem of transudate forma-
tion across the graft material. Gore reports a decrease in
transudate formation in a bench model with these modifi-
cations.
Treatment options for perigraft seromas include simple
observation, incision and drainage, aspiration of the fluid,
and replacement of the graft. The reported success rates in
the survey by Blumenberg et al5 were best with graft
replacement (92%), and lowest with incision and drainage
(53%).
Our patient underwent an open incision and drainage
of his symptomatic perigraft seroma during the first opera-
tion and experienced resolution of his pain. Unfortunately,
this provided only a few months of relief before seroma
reaccumulated and his symptoms recurred.
In the symptomatic patient, a trial of percutaneous
aspiration or open drainage may be warranted to provide
relief and aid in diagnosis. If the fluid is infected or the
Fig 3. Computed tomography scan demonstrates recurrent aor-
tic sac seroma.patient has recurrence of the seroma, then the graft shouldbe excised. Asymptomatic perigraft seromas or sac expan-
sion without endoleaks should be followed closely for signs
of graft migration or development of symptoms such as
abdominal pain, nausea, fullness, or obstruction of the
ureter or bowel.
Based on our report, the observations of other sur-
geons, and the acknowledgment of transudate formation
by the manufacturer of a PTFE graft, we recommend
continued vigilance in monitoring both open and endovas-
cular PTFE grafts as well as further investigation into the
significance and treatment of aortic perigraft seromas.
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